Workflow
思创医惠(300078) - 2024 Q4 - 年度业绩预告
CENTURYCENTURY(SZ:300078)2025-01-15 08:26

Financial Performance Expectations - The company expects a net loss of between 419.17 million RMB and 628.75 million RMB for the fiscal year 2024, compared to a loss of 874.35 million RMB in the same period last year[4]. - Operating revenue is projected to be between 541.64 million RMB and 812.46 million RMB, down from 1,005.93 million RMB in the previous year[4]. Impairment and Asset Management - The company plans to recognize an impairment loss on goodwill of approximately 69 million RMB, subject to final assessment by professional evaluation and audit firms[7]. - The amount of various asset impairments (fixed assets, intangible assets, inventory, long-term equity investments) is expected to decrease compared to the same period last year[7]. Factors Affecting Revenue - The decline in overall operating revenue is attributed to market competition, adjustments in business models, and a decrease in order volume[7]. Cost Control Measures - The company has implemented cost control measures, resulting in a reduction of sales and management expenses, contributing to a decrease in financial costs year-on-year[7]. Financial Data and Reporting - The company has communicated with Tianjian Accounting Firm regarding the preliminary financial data, and there are no discrepancies in the earnings forecast[5]. - The financial data provided is preliminary and has not yet been audited by the accounting firm[8]. - Detailed financial data will be disclosed in the 2024 annual report, urging investors to make cautious decisions and be aware of investment risks[8]. - The reporting period for the earnings forecast is from January 1, 2024, to December 31, 2024[3].